2024 White Paper on Recent Issues in Bioanalysis: Three Way-Cross Validation; Urine Clinical Analysis; Automated Methods; Regulatory Queries on Plasma Protein Binding; Automated Biospecimen Management; ELN Migration; Ultra-Sensitivity Mass Spectrometry (<underline>Part 1A</underline> - Recommendations on Advanced Strategies for Mass Spectrometry Assays, Chromatography, Sample Preparation and BMV/Regulated Bioanalysis <underline>Part 1B</underline> - Regulatory Agencies' Inputs on Regulated Bioanalysis/BMV)

被引：0

作者：

Wojcik, John ^{[1
]}

Sikorski, Timothy ^{[2
]}

Wang, Jian ^{[3
]}

Huang, Yue ^{[4
]}

Sugimoto, Hiroshi ^{[5
]}

Baratta, Mike ^{[5
]}

Ciccimaro, Eugene ^{[6
]}

Green, Rachel ^{[7
]}

Jian, Wenying ^{[8
]}

Kar, Sumit ^{[9
]}

Kim, Yeoun Jin ^{[10
]}

Lassman, Michael ^{[1
]}

Mohapatra, Susovan ^{[11
]}

Qian, Mark ^{[5
]}

Rosenbaum, Anton I. ^{[12
]}

Sarvaiya, Hetal ^{[13
]}

Tian, Yu ^{[14
]}

Vainshtein, Inna ^{[15
]}

Yuan, Long ^{[16
]}

Tao, Lin ^{[20
]}

Ji, Allena ^{[17
]}

Kochansky, Christopher ^{[18
]}

Qiu, Haibo ^{[19
]}

Maes, Estelle ^{[29
]}

Chen, Lin-Zhi ^{[21
]}

Cooley, Megan ^{[22
]}

Dufield, Dawn ^{[23
]}

Hyer, Elizabeth ^{[24
]}

Johnson, Jay ^{[43
]}

Li, Wenkui ^{[26
]}

Liu, Aihua ^{[27
]}

Lu, Yang ^{[28
]}

Meissen, John ^{[12
]}

Palandra, Joe ^{[5
]}

Tang, Xiaonan ^{[30
]}

Vigil, Adam ^{[19
]}

Wei, Wei ^{[21
]}

Vinter, Stephen ^{[31
]}

Xue, Yongjun ^{[6
]}

Yang, Li ^{[28
]}

Zheng, Naiyu ^{[6
]}

Benson, Kimberly ^{[28
]}

Mccush, Fred ^{[25
]}

Liang, Zhenmin ^{[32
]}

Abberley, Lee ^{[2
]}

Andisik, Matthew ^{[19
]}

Araya, Marcela ^{[25
]}

Cho, Seongeun ^{[28
]}

Colligan, Liliana ^{[19
]}

Dasgupta, Arindam ^{[28
]}

机构：

[1] Merck, West Point, PA USA

[2] GlaxoSmithKline, Collegeville, PA USA

[3] Crinetics, San Diego, CA USA

[4] Revolut Med, South San Francisco, CA USA

[5] Takeda, Cambridge, MA USA

[6] Bristol Myers Squibb, Lawrenceville, NJ USA

[7] Complement Stevenage, Stevenage, England

[8] Johnson & Johnson Innovat Med, Spring House, PA USA

[9] WRIB, Toronto, ON, Canada

[10] AstraZeneca, Gaithersburg, MD USA

[11] Stoke, Bedford, MA USA

[12] AstraZeneca, South San Francisco, CA USA

[13] AbbVie, San Mateo, CA USA

[14] AbbVie, Worcester, MA USA

[15] Exelixis, Alameda, CA USA

[16] Biogen, Cambridge, MA USA

[17] Chiesi, Boston, MA USA

[18] Exelixis, King Of Prussia, PA USA

[19] Regeneron, Tarrytown, NY USA

[20] Sanofi, Framingham, MA USA

[21] Boehringer Ingelheim GmbH & Co KG, Ridgefield, CT USA

[22] ICON, Lenexa, KS USA

[23] KCASBio, Olathe, KS USA

[24] Labcorp, Madison, WI USA

[25] Pfizer, Groton, CT USA

[26] Novartis, E Hanover, NJ USA

[27] Resolian, Berwyn, PA USA

[28] US FDA, Silver Spring, MD USA

[29] AbbVie, Chicago, IL USA

[30] Frontage, Exton, PA USA

[31] UK MHRA, London, England

[32] Vertex, Boston, MA USA

[33] Sanofi, Frankfurt, Germany

[34] Hlth Canada, Ottawa, ON, Canada

[35] Genentech Inc, San Francisco, CA USA

[36] BRI Frontage, Vancouver, BC, Canada

[37] Japan MHLW, Tokyo, Japan

[38] Dutch IGJ, Randstad, Netherlands

[39] Pfizer, Bothell, WA USA

[40] Brazil ANVISA, Brasilia, Brazil

[41] Johnson & Johnson Innovat Med, Beerse, Belgium

[42] Pfizer, San Diego, CA USA

[43] Pfizer, Andover, MA USA

来源：

BIOANALYSIS | 2025年 / 17卷 / 05期

关键词：

bioanalysis; biomarkers; cell therapy; gene therapy; immunogenicity; vaccine; WRIB; PART 2-HYBRID LBA/LCMS; SMALL MOLECULES; FULL IMMERSION; 1-SMALL MOLECULES; FACTOR-H; BIOMARKERS; FOCUS; 3-LBA; IMMUNOGENICITY; TECHNOLOGIES;

D O I：

10.1080/17576180.2025.2450194

中图分类号：

Q5 [生物化学];

学科分类号：

071010 ; 081704 ;

摘要：

The 18(th) Workshop on Recent Issues in Bioanalysis (18(th) WRIB) took place in San Antonio, TX, USA on May 6-10, 2024. Over 1100 professionals representing pharma/biotech companies, CROs, and multiple regulatory agencies convened to actively discuss the most current topics of interest in bioanalysis. The 18th WRIB included 3 Main Workshops and 7 Specialized Workshops that together spanned 1 week to allow an exhaustive and thorough coverage of all major issues in bioanalysis of biomarkers, immunogenicity, gene therapy, cell therapy and vaccines. Moreover, in-depth workshops on "IVDR Implementation in EU & Changes for LDT in the US" and on "Harmonization of Vaccine Clinical Assays Validation" were the special features of the 18(th) edition. As in previous years, WRIB continued to gather a wide diversity of international, industry opinion leaders and regulatory authority experts working on both small and large molecules as well as gene, cell therapies and vaccines to facilitate sharing and discussions focused on improving quality, increasing regulatory compliance, and achieving scientific excellence on bioanalytical issues. This 2024 White Paper encompasses recommendations emerging from the extensive discussions held during the workshop and is aimed to provide the bioanalytical community with key information and practical solutions on topics and issues addressed, in an effort to enable advances in scientific excellence, improved quality and better regulatory compliance. Due to its length, the 2024 edition of this comprehensive White Paper has been divided into three parts for editorial reasons. This publication (Part 1) covers in Part 1A the Recommendations on Mass Spectrometry Assays and Regulated Bioanalysis/BMV and in Part 1B the Regulatory Inputs on these topics. Part 3 (Gene Therapy, Cell therapy, Vaccines and Biotherapeutics Immunogenicity) and Part 2 (Biomarkers/BAV, IVD/CDx, LBA and Cell-Based Assays) are published in volume 17 of Bioanalysis, issues 3 and 4 (2025), respectively.

引用

页码：299 / 337

页数：39

共 58 条

[1] 2015 White Paper on recent issues in bioanalysis: focus on new technologies and biomarkers (Part 2-hybrid LBA/LCMS and input from regulatory agencies) [J].

Ackermann, Brad ;

Neubert, Hendrik ;

Hughes, Nicola ;

Garofolo, Fabio ;

Abberley, Lee ;

Alley, Stephen C. ;

Brown-Augsburger, Patricia ;

Bustard, Mark ;

Chen, Lin-zhi ;

Heinrich, Julia ;

Katori, Noriko ;

Kaur, Surinder ;

Kirkovsky, Leo ;

Laterza, Omar F. ;

Le Blaye, Olivier ;

Levesque, Ann ;

Lima Santos, Gustavo Mendes ;

Olah, Timothy ;

Savoie, Natasha ;

Skelly, Michael ;

Spitz, Susan ;

Szapacs, Matthew ;

Tampal, Nilufer ;

Wang, Jian ;

Welink, Jan ;

Wieling, Jaap ;

Haidar, Sam ;

Vinter, Stephen ;

Whale, Emma ;

Witte, Baerbel .

BIOANALYSIS, 2015, 7 (23) :3019-3034

[2] 2015 White Paper on recent issues in bioanalysis: focus on new technologies and biomarkers (Part 3-LBA, biomarkers and immunogenicity) [J].

Amaravadi, Lakshmi ;

Song, An ;

Myler, Heather ;

Thway, Theingi ;

Kirshner, Susan ;

Devanarayan, Viswanath ;

Ni, Yan G. ;

Garofolo, Fabio ;

Birnboeck, Herbert ;

Richards, Susan ;

Gupta, Shalini ;

Luo, Linlin ;

Kingsley, Clare ;

Salazar-Fontana, Laura ;

Fraser, Stephanie ;

Gorovits, Boris ;

Allinson, John ;

Barger, Troy ;

Chilewski, Shannon ;

Fjording, Marianne Scheel ;

Haidar, Sam ;

Islam, Rafiqul ;

Jaitner, Birgit ;

Kamerud, John ;

Katori, Noriko ;

Krinos-Fiorotti, Corinna ;

Lanham, David ;

Ma, Mark ;

McNally, Jim ;

Morimoto, Alyssa ;

Mytych, Daniel ;

da Costa, Andre Nogueira ;

Papadimitriou, Apollon ;

Pillutla, Renuka ;

Ray, Soma ;

Safavi, Afshin ;

Savoie, Natasha ;

Schaefer, Martin ;

Shih, Judy ;

Smeraglia, John ;

Skelly, Michael F. ;

Spond, Jeffrey ;

Staack, Roland F. ;

Stouffer, Bruce ;

Tampal, Nilufer ;

Torri, Albert ;

Welink, Jan ;

Yang, Tong-Yuan ;

Zoghbi, Jad .

BIOANALYSIS, 2015, 7 (24) :3107-3124

[3]

[Anonymous], 2018, Bioanalytical method validation guidance for industry

[4] The complement system in age-related macular degeneration [J].

Armento, Angela ;

Ueffing, Marius ;

Clark, Simon J. .

CELLULAR AND MOLECULAR LIFE SCIENCES, 2021, 78 (10) :4487-4505

[5] 2023 White Paper on Recent Issues in Bioanalysis: Deuterated Drugs; LNP; Tumor/FFPE Biopsy; Targeted Proteomics; Small Molecule Covalent Inhibitors; Chiral Bioanalysis; Remote Regulatory Assessments; Sample Reconciliation/Chain of Custody <underline>(PART 1A</underline> - Recommendations on Mass Spectrometry, Chromatography, Sample Preparation Latest Developments, Challenges, and Solutions and BMV/Regulated Bioanalysis <underline>PART 1B</underline> - Regulatory Agencies' Inputs on Regulated Bioanalysis/BMV, Biomarkers/IVD/CDx/BAV, Immunogenicity, Gene & Cell Therapy and Vaccine) [J].

Baratta, Mike ;

Jian, Wenying ;

Hengel, Shawna ;

Kaur, Surinder ;

Cunliffe, Jennifer ;

Boer, Jason ;

Hughes, Nicki ;

Kar, Sumit ;

Kellie, John ;

Kim, Yeoun Jin ;

Lassman, Michael ;

Mehl, John ;

Morgan, Ling ;

Palandra, Joe ;

Sarvaiya, Hetal ;

Zeng, Jianing ;

Zheng, Naiyu ;

Wang, Jian ;

Yuan, Long ;

Ji, Allena ;

Kochansky, Christopher ;

Tao, Lin ;

Huang, Yue ;

Maes, Estelle ;

Barbero, Luca ;

Contrepois, Kevin ;

Ferrari, Luca ;

Fu, Yunlin ;

Johnson, Jay ;

Jones, Barry ;

Kansal, Monika ;

Lu, Yang ;

Post, Noah ;

Shen, Honglue ;

Xue, Yongjun ;

Zhang, Yiyue ;

Biswas, Gopa ;

Cho, Seongeun ;

Edmison, Anna ;

Benson, Kimberly ;

Abberley, Lee ;

Azadeh, Mitra ;

Francis, Jennifer ;

Garofolo, Fabio ;

Gupta, Shalini ;

Ivanova, Iordanka ;

Ishii-Watabe, Akiko ;

Karnik, Shane ;

Kassim, Sean ;

Kavetska, Olga .

BIOANALYSIS, 2024, 16 (09) :307-364

[6] OSWG Recommended Approaches to the Nonclinical Pharmacokinetic (Absorption, Distribution, Metabolism, and Excretion) Characterization of Therapeutic Oligonucleotides [J].

Berman, Cindy L. ;

Antonsson, Madeleine ;

Batkai, Sandor ;

Bosgra, Sieto ;

Chopda, Girish R. ;

Driessen, Wouter ;

Foy, Jeffrey ;

Hassan, Chopie ;

Hu, Xiao Shelley ;

Jang, Hyun Gyung ;

Meena ;

Sanseverino, Mark ;

Thum, Thomas ;

Wang, Yanfeng ;

Wild, Martin ;

Wu, Jing-Tao .

NUCLEIC ACID THERAPEUTICS, 2023, 33 (05) :287-305

[7] Exploiting protease activation for therapy [J].

Bleuez, Chloe ;

Koch, Wolfgang F. ;

Urbach, Carole ;

Hollfelder, Florian ;

Jermutus, Lutz .

DRUG DISCOVERY TODAY, 2022, 27 (06) :1743-1754

[8] 2019 White Paper On Recent Issues in Bioanalysis: FDA BMV Guidance, ICH M10 BMV Guideline and Regulatory Inputs (Part 2-Recommendations on 2018 FDA BMV Guidance, 2019 ICH M10 BMV Draft Guideline and Regulatory Agencies' Input on Bioanalysis, Biomarkers and Immunogenicity) [J].

Booth, Brian ;

Stevenson, Lauren ;

Pillutla, Renuka ;

Buonarati, Michael ;

Beaver, Chris ;

Fraier, Daniela ;

Garofolo, Fabio ;

Haidar, Sam ;

Islam, Rafiq ;

James, Christopher ;

Kadavil, John ;

Kavetska, Olga ;

Li, Fumin ;

Satterwhite, Christina ;

Savoie, Natasha ;

Subramaniam, Sriram ;

Tampal, Nilufer ;

Thway, Theingi ;

Woolf, Eric ;

Le Blaye, Olivier ;

Andisik, Matthew ;

Briscoe, Chad ;

Cape, Stephanie ;

Dasgupta, Arindam ;

Fischer, Sally ;

Hayes, Roger ;

Kamerud, John ;

Lima Santos, Gustavo Mendes ;

Nehls, Corey ;

Soo, Catherine ;

Vinter, Stephen ;

Whale, Emma ;

Xu, Keyang ;

Cho, Seongeun ;

Edmison, Anna ;

Kassim, Sean ;

Rocha, Thais Correa ;

Welink, Jan ;

Amur, Shashi ;

Bandukwala, Abbas ;

Cherry, Elana ;

Hopper, Shirley ;

Ishii-Watabe, Akiko ;

Kirshner, Susan ;

Maher, Kevin ;

Pedras-Vasconcelos, Joao ;

Saito, Yoshiro ;

Saunders, Therese Solstad ;

Skibeli, Venke ;

Verthelyi, Daniela .

BIOANALYSIS, 2019, 11 (23) :2099-2132

[9] Hybrid assays: the next big thing? [J].

Booth, Brian P. ;

Furmanski, Brian .

BIOANALYSIS, 2018, 10 (13) :975-977

[10] Mass spectrometry quantifies target engagement for a KRASG12C inhibitor in FFPE tumor tissue [J].

Chambers, Andrew G. ;

Chain, David C. ;

Sweet, Steve M. ;

Song, Zifeng ;

Martin, Philip L. ;

Ellis, Matthew J. ;

Rooney, Claire ;

Kim, Yeoun Jin .

CLINICAL PROTEOMICS, 2023, 20 (01)

← 1 2 3 4 5 6 →